Agilent Technologies has signed a definitive agreement to acquire privately-held Advanced Analytical Technologies, (AATI), a provider of capillary electrophoresis-based (CE) solutions for fully-automated analysis of a range of molecules for $ 250 million in cash.
Santa/Clara — Automated electrophoresis is a commonly used separation technique to analyze biomolecules such as nucleic acids (RNA and DNA), proteins, carbohydrates and small molecules. It has a broad range of applications and is used across a variety of industries segments including pharma and biopharma, academia and government, clinical and diagnostics, food, environmental and forensics, and chemical and energy.
AATI has developed compelling CE technologies that provide key advances in sensitivity and resolution to address a wide range of applications. AATI solutions are comprised of instruments, software and consumables aimed at simplifying complex workflows. Founded in 1998, AATI is based in Ankeny, Iowa and employs 101 employees.
According to Dr. Stefan Schuette, vice president and general manager of Agilent’s Liquid Phase Separations Division, technology advances in genomics, metabolomics, and proteomics were driving growth and demand for innovative new solutions.
The transaction is subject to customary closing conditions and regulatory approval.